Results 21 to 30 of about 22,527 (249)

Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study.

PLoS ONE, 2023
ObjectivesWe examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk ...
Xenia Begun, Jawad Haider Butt, Søren Lund Kristensen, Peter Ejvin Weeke, Ole De Backer, Morten Schou, Lars Køber, Emil Loldrup Fosbøl   +7 more
doaj   +1 more source

Adherence to Pharmacotherapies After Heart Transplantation in Relation to Multimorbidity and Socioeconomic Position: A Nationwide Register-Based Study

Transplant International, 2023
No studies have examined the impact of multimorbidity and socioeconomic position (SEP) on adherence to the pharmacological therapies following heart transplantation (HTx).
Rikke E. Mols, Rikke E. Mols, István Bakos, Brian B Løgstrup, Brian B Løgstrup, Erzsébet Horváth-Puhó, Finn Gustafsson, Finn Gustafsson, Hans Eiskjær, Hans Eiskjær   +9 more
doaj   +1 more source

European Consensus on use of diuretics in chronic heart failure 2019

Медицинский совет, 2020
The article presents the consensus materials of the European Society of Cardiology on the use of diuretics in chronic heart failure (CHF). Diuretics represent an important class of drugs for the treatment of heart failure from the perspective of evidence
M. V. Leonova
doaj   +1 more source

Prevalence of thiamine deficiency in heart failure patients on long-term diuretic therapy

Journal of the Practice of Cardiovascular Sciences, 2015
Background: Loop diuretics are an integral part of heart failure management. It has been shown that loop diuretics cause thiamine deficiency (TD) by increasing its urinary loss. The aim of this study was to determine the prevalence of TD in heart failure
Shrenik Doshi, T Velpandian, Sandeep Seth, S K Maulik, Balram Bhargava, Vinay K Bahl   +5 more
doaj   +1 more source

Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background In acute decompensated heart failure, guidelines recommend increasing loop diuretic dose or adding a thiazide diuretic when diuresis is inadequate.
Meredith A. Brisco‐Bacik, Jozine M. ter Maaten, Steven R. Houser, Natasha A. Vedage, Veena Rao, Tariq Ahmad, F. Perry Wilson, Jeffrey M. Testani   +7 more
doaj   +1 more source

Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center Study

Medicines, 2020
Background: The pharmacologic management of heart failure with preserved ejection fraction (HFpEF) involves far fewer options with demonstrated additional benefit.
Priyanka Parajuli, Odalys Estefania Lara-Garcia, Manjari Rani Regmi, Warren Skoza, Mukul Bhattarai, Abhishek Kulkarni, Robert Leonard Robinson   +6 more
doaj   +1 more source

Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching.

PLoS ONE, 2015
BACKGROUND:Loop diuretics are widely used in patients with heart and renal failure, as well as to treat hypertension and peripheral edema. However, there are no randomized, controlled trials (RCT) evaluating their long term safety, and several ...
Hall Schartum-Hansen, Kjetil H Løland, Gard F T Svingen, Reinhard Seifert, Eva R Pedersen, Jan E Nordrehaug, Øyvind Bleie, Marta Ebbing, Christ Berge, Dennis W T Nilsen, Ottar Nygård   +10 more
doaj   +1 more source

BENFOTHIAMINE ADMINISTRATION IN PATIENTS WITH DILATED CARDIOMYOPATHY AND ADVANCED HEART FAILURE WITH CHRONIC DIURETIC TREATMENT

Studia Universitatis Babes-Bolyai Chemia, 2017
It is well known that long term administration of high dose loop diuretics in patients with heart failure, may in some cases aggravate the cardiac failure symptoms. Part of this effect may be due to thiamine depletion secondary to diuretics use. The aim
Dana-Adriana ILUȚIU-VARVARA, Dan RĂDULESCU, Valer Ioan DONCA   +2 more
doaj   +1 more source

Sequential Blockade with Loop Diuretics and Acetazolamide: A Novel Strategy in Acute Heart Failure

Journal of the Indian Academy of Geriatrics
Acute decompensated heart failure (HF) is the most common form of acute HF (AHF) and presents with systemic congestion due to left ventricular dysfunction with sodium and water retention.
Nitin R. Gaikwad, Madhusudan Prasad Singh, Alok Singh   +2 more
doaj   +1 more source

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial

Kidney Diseases
Introduction: VERTIS CV was a placebo-controlled cardiovascular (CV) outcome trial evaluating the sodium-glucose cotransporter 2 inhibitor ertugliflozin in patients with type 2 diabetes and established atherosclerotic CV disease.
David Z.I. Cherney, Robert Frederich, Richard E. Pratley, Francesco Cosentino, Samuel Dagogo-Jack, Annpey Pong, Ira Gantz, Nilo B. Cater, James P. Mancuso, Urszula Masiukiewicz, Christopher P. Cannon   +10 more
doaj   +1 more source